Post written by: BioTech Health X
You May Also Like
PharmaCyte Biotech Announces Uplist to Nasdaq Capital Market and Public Offering
- BioTech Health X
- August 9, 2021
- 3 minute read
Biotechnology company PharmaCyte Biotech, Inc. (OTCQB: PMCBD), a company concentrated on creating cellular therapies for cancer cells and…
FDA Approves Biosimilars Yesafili and Opuviz, Opening New Avenues for Affordable Eye Treatments
- BioTech Health X
- May 21, 2024
- 2 minute read
Table of Contents Hide About Yesafili (aflibercept-jbvf)About Opuviz (aflibercept-yszy)Market Impact and SignificanceThe Growing Biosimilars MarketWhat’s Next The FDA…
Rapid Dose Therapeutics Announces Formation & Appointment of Advisory Board
- BioTech Health X
- July 22, 2021
- 3 minute read
Table of Contents Hide Ron BrooksNick DiRenzoAnne LachanceRapid Dose CEO Mark Upsdell Comment Rapid Dose Therapeutics (CSE:DOSE) is…
TaiMed Biologics Unveils Promising Results for Innovative Long-Acting HIV Treatment
- BioTech Health X
- October 16, 2023
- 2 minute read
TaiMed Biologics, a pioneering biotechnology firm, has marked a significant milestone in the fight against HIV. The company…
Coherus Presents Promising Phase I Results for Anti-CCR8 Antibody CHS-114 at ASCO 2024
- BioTech Health X
- May 23, 2024
- 2 minute read
Table of Contents Hide Company BackgroundMarket FocusDrugs HistoryRecent DevelopmentsWhat’s Ahead Coherus BioSciences has announced preliminary results from its…
Infinity Pharmaceuticals Add 2 New Members to Board of Directors
- BioTech Health X
- September 7, 2021
- 3 minute read
Table of Contents Hide About Infinity PharmaceuticalsAbout Dr. Robert Ilaria – Infinity Pharmaceuticals Chief Medical OfficerAbout Dr. Brian…